Merck announced today the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for DIFICID® (fidaxomicin) for oral suspension, and a supplemental New Drug Application (sNDA)...

New diagnostic methods and treatments – including fecal transplantation – will help improve the care of patients with Clostridium difficile (C. diff.), a deadly bacterial infection that can occur...